-+ 0.00%
-+ 0.00%
-+ 0.00%

SELLAS LIFE SCIENCES GROUP INC - TOPLINE DATA FROM PHASE 2 TRIAL EXPECTED IN Q4 2026

Reuters·03/12/2026 12:35:00

Please log in to view news